BIOMARIN PHARMACEUTICAL INC
BMRN · NASDAQ
更新於 2026-10-15 15:26:20
- 今日最高
- $57.60
- 今日最低
- $55.96
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $54.75
- 昨天收盤價
- $55.14
- 成交量
- 1.84M
- 市值
- $10.67B
- 市盈率（P/E）
- 145.99X
- 每股收益（EPS）
- $0.36
昨天價格區間
52週價格區間
公司概況
- 板塊
- HEALTHCARE
- 行業
- Biotechnology
- 子行業
- BIOTECHNOLOGY
- 總部
- 770 LINDARO STREET, SAN RAFAEL, CA, UNITED STATES, 94901
- 國家
- US
- 上市日期
- 1999-07-23
- 財年截止
- December
- 流通股數
- 193.28M
- CIK
- 0001048477
- 官方網址
- www.biomarin.com
BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San Rafael, California.
財務指標
營業收入
2026-06-30
$989.7M
2026-03-31
$766.2M
2025-12-31
$874.56M
2025-09-30
$776.13M
營業支出
2026-06-30
$675.98M
2026-03-31
$441.57M
2025-12-31
$500.08M
2025-09-30
$682.74M
淨利潤
2026-06-30
$44.76M
2026-03-31
$105.52M
2025-12-31
-$46.57M
2025-09-30
-$30.74M
淨利潤率
2026-06-30
4.52%
2026-03-31
13.77%
2025-12-31
-5.32%
2025-09-30
-3.96%
每股收益
2026-06-30
$0.90
2026-03-31
$0.76
2025-12-31
$0.46
2025-09-30
$0.12
息稅折舊攤銷前利潤
2026-06-30
$222.31M
2026-03-31
$172.57M
2025-12-31
-$3.93M
2025-09-30
-$5.25M
有效稅率
2026-06-30
27.07%
2026-03-31
25.26%
2025-12-31
-71.52%
2025-09-30
-16.79%
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $989.7M | $766.2M | $874.56M | $776.13M |
| 營業支出 | $675.98M | $441.57M | $500.08M | $682.74M |
| 淨利潤 | $44.76M | $105.52M | -$46.57M | -$30.74M |
| 淨利潤率 | 4.52% | 13.77% | -5.32% | -3.96% |
| 每股收益 | $0.90 | $0.76 | $0.46 | $0.12 |
| 息稅折舊攤銷前利潤 | $222.31M | $172.57M | -$3.93M | -$5.25M |
| 有效稅率 | 27.07% | 25.26% | -71.52% | -16.79% |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。